Answers are grounded in this paper and cite their sources.
// Amir Mehrvarz Sarshekeh 1 , Shailesh Advani 1 , Daniel M. Halperin 1 , Claudius Conrad 2 , Chan Shen 3 , James C. Yao 1 and Arvind Dasari 1 1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 2 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 3 Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Correspondence to: Arvind Dasari, email: adasari@mdanderson.org Keywords: appendix, neuroendocrine, right hemicolectomy, survival, tumor size Received: May 09, 2017 Accepted: June 30, 2017 Published: August 19, 2017 ABSTRACT Background: Appendiceal neuroendocrine neoplasms are most often diagnosed incidentally during appendectomy. The need for subsequent right hemicolectomy (RHC) is determined based on the risk of regional lymph node (LN) involvement. Tumor size has historically been used as an indicator of this risk, but controversy remains regarding its cut off. Furthermore, the impact of RHC on survival is unclear. Methods: We used the SEER database to identify patients diagnosed with appendiceal neuroendocrine tumors. Results: Of 1731 patients, 38.0% had well-differentiated neuroendocrine tumors (WDNETs), 60.8% had mixed histology tumors (MHTs), and 1.2% had poorly differentiated neuroendocrine carcinomas (PDNECs). In patients with WDNETs and MHTs who had adequate lymphadenectomy, higher rates of LN involvement were noted for tumors size 11–20 mm than ≤10 mm (56.8% vs. 11.6%, p <0.001; 32.9% vs. 10.4%, p =0.004, respectively). The type of surgery did not affect OS in cases with MHTs with LN involvement (HR 1.00; 95% CI, 0.53–1.89; p =0.99). Patients with regionally advanced WDNET showed excellent survival and only 3 patients (out of 118) died from cancer within 10 years. Conclusions: 10 mm appears to be a more appropriate cutoff than 20 mm for predicting LN metastasis in appendiceal NETs. Cases with WDNETs and nodal involvement demonstrate overall excellent prognosis irrespective of type of surgery (i.e. RHC may not improve outcome). In MHTs with LN metastases, survival is markedly worse in spite of RHC. The role of adjuvant therapy should be evaluated in this subset.
No takes yet. Share an insight, caveat, or question.
Sarshekeh et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: